Subha Subramanian

Feb 13, 2024 | biologicalpsychiatryjournal.com | Joshua Siegel |Subha Subramanian |Nico U.F. Dosenbach |Ginger E. Nicol

A single dose of psilocybin has been shown to have persistent antidepressant effects in human clinical trials. In animal models, psilocybin induces neuroplasticity in cortex and hippocampus. Deciphering the acute and persistent effects of psilocybin on the human brain is a critical step towards better understanding the neurobiology of psychedelics.